These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 21672048)

  • 1. Efficacy of anidulafungin against biofilms of different Candida species in long-term trials of continuous flow cultivation.
    Bernhardt H; Knoke M; Bernhardt J
    Mycoses; 2011 Nov; 54(6):e821-7. PubMed ID: 21672048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Candida parapsilosis complex isolates.
    de Toro M; Torres MJ; Maite R; Aznar J
    Clin Microbiol Infect; 2011 Mar; 17(3):418-24. PubMed ID: 20636431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of anidulafungin in combination with amphotericin B or voriconazole against biofilms of five Candida species.
    Valentín A; Cantón E; Pemán J; Fernandez-Rivero ME; Tormo-Mas MA; Martínez JP
    J Antimicrob Chemother; 2016 Dec; 71(12):3449-3452. PubMed ID: 27543657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additive antifungal activity of anidulafungin and human neutrophils against Candida parapsilosis biofilms.
    Katragkou A; Chatzimoschou A; Simitsopoulou M; Georgiadou E; Roilides E
    J Antimicrob Chemother; 2011 Mar; 66(3):588-91. PubMed ID: 21138910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voriconazole inhibits biofilm formation in different species of the genus Candida.
    Valentín A; Cantón E; Pemán J; Martínez JP
    J Antimicrob Chemother; 2012 Oct; 67(10):2418-23. PubMed ID: 22733651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Species-specific differences in the susceptibilities of biofilms formed by Candida bloodstream isolates to echinocandin antifungals.
    Choi HW; Shin JH; Jung SI; Park KH; Cho D; Kee SJ; Shin MG; Suh SP; Ryang DW
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1520-3. PubMed ID: 17283191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigation of antifungal susceptibilities and some virulence factors of Candida strains isolated from blood cultures and genotyping by RAPD-PCR].
    Gültekin B; Eyigör M; Tiryaki Y; Kırdar S; Aydın N
    Mikrobiyol Bul; 2011 Apr; 45(2):306-17. PubMed ID: 21644074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro effectiveness of anidulafungin against Candida sp. biofilms.
    Rosato A; Piarulli M; Schiavone BP; Catalano A; Carocci A; Carrieri A; Carone A; Caggiano G; Franchini C; Corbo F; Montagna MT
    J Antibiot (Tokyo); 2013 Dec; 66(12):701-4. PubMed ID: 24022607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and antifungal susceptibility patterns of new cryptic species inside the species complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital.
    Miranda-Zapico I; Eraso E; Hernández-Almaraz JL; López-Soria LM; Carrillo-Muñoz AJ; Hernández-Molina JM; Quindós G
    J Antimicrob Chemother; 2011 Oct; 66(10):2315-22. PubMed ID: 21795259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Activity of anidulafungin against Candida biofilms].
    Pemán J; Cantón E; Valentín A
    Rev Iberoam Micol; 2008 Jun; 25(2):124-8. PubMed ID: 18473507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ambroxol influences voriconazole resistance of Candida parapsilosis biofilm.
    Pulcrano G; Panellis D; De Domenico G; Rossano F; Catania MR
    FEMS Yeast Res; 2012 Jun; 12(4):430-8. PubMed ID: 22315984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of serum on in vitro susceptibility testing of echinocandins for Candida parapsilosis and Candida guilliermondii.
    Saribas Z; Yurdakul P; Cetin-Hazirolan G; Arikan-Akdagli S
    Mycoses; 2012 Mar; 55(2):156-60. PubMed ID: 21668525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activities of triazole-echinocandin combinations against Candida species in biofilms and as planktonic cells.
    Chatzimoschou A; Katragkou A; Simitsopoulou M; Antachopoulos C; Georgiadou E; Walsh TJ; Roilides E
    Antimicrob Agents Chemother; 2011 May; 55(5):1968-74. PubMed ID: 21343465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the broth microdilution (BMD) method of the European Committee on Antimicrobial Susceptibility Testing and the Clinical Laboratory Standards Institute BMD method for non-Candida albicans and non-C. tropicalis bloodstream isolates from eleven tertiary hospitals in São Paulo state, Brazil.
    Purisco SU; Martins MA; Szeszs MW; Castro e Silva DM; Pukinskas SR; Bonfietti LX; Baez AA; Melhem MS
    FEMS Yeast Res; 2012 Dec; 12(8):890-6. PubMed ID: 22883021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
    Takakura S; Fujihara N; Saito T; Kudo T; Iinuma Y; Ichiyama S
    J Antimicrob Chemother; 2004 Feb; 53(2):283-9. PubMed ID: 14688039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009).
    Pfaller MA; Messer SA; Moet GJ; Jones RN; Castanheira M
    Int J Antimicrob Agents; 2011 Jul; 38(1):65-9. PubMed ID: 21514797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of xanthorrhizol against Candida glabrata, C. guilliermondii, and C. parapsilosis biofilms.
    Rukayadi Y; Han S; Yong D; Hwang JK
    Med Mycol; 2011 Jan; 49(1):1-9. PubMed ID: 20560862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans, and Aspergillus fumigatus: application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009).
    Pfaller MA; Castanheira M; Messer SA; Moet GJ; Jones RN
    Diagn Microbiol Infect Dis; 2011 Jan; 69(1):45-50. PubMed ID: 21146713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the Sensititre YeastOne colorimetric antifungal panel with CLSI microdilution for antifungal susceptibility testing of the echinocandins against Candida spp., using new clinical breakpoints and epidemiological cutoff values.
    Pfaller MA; Chaturvedi V; Diekema DJ; Ghannoum MA; Holliday NM; Killian SB; Knapp CC; Messer SA; Miskou A; Ramani R
    Diagn Microbiol Infect Dis; 2012 Aug; 73(4):365-8. PubMed ID: 22726528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [What distinctions do Candida biofilms have to offer?].
    Bernhardt H; Knoke M
    Mycoses; 2008 Sep; 51 Suppl 3():33-8. PubMed ID: 18782243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.